Batch report — flagship
RETP002
Flagship Reta 30mg Pen — 300 clicks at 0.1 mg per click. Janoshik Analytical tested batch RETP002 on 4 November 2025 at 99.262% HPLC purity. The original PDF is mirrored from the source archive.
For in-vitro laboratory research only. Not for human or veterinary use.
Batch facts
- Format
- Reta 30mg Pen — 300 clicks at 0.1 mg/click
- Batch number
RETP002- Molecule
- Reta (LY-3437943) — CAS 2381089-83-2
- Purity (HPLC)
- 99.262%
- Test method
- HPLC (High-Performance Liquid Chromatography)
- Laboratory
- Janoshik Analytical
- Analysis date
- 4 November 2025
Janoshik report
The original Janoshik COA for the flagship 30mg pen release. Image and PDF are mirrored from the Janoshik original.
Common questions
What is batch RETP002?
The flagship Reta 30mg Pen release. Janoshik Analytical tested it 4 November 2025 at 99.262% HPLC purity.
Which format is associated with batch RETP002?
The flagship Reta 30mg Pen — 300 clicks at 0.1 mg per click. Associated with the Remy 30mg pen reference.
Where is the original Janoshik report?
The full PDF and report image are mirrored locally on Remy Research from the Janoshik original.
Continue through the evidence trail
This page documents the flagship 30mg pen batch evidence first. When the proof checks out, research-use availability for the Reta 30mg Pen lives on Remy Peptides.